Wearable Adherence Monitoring With Real-Time Patient Feedback

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current medication adherence (MA) monitoring systems fail to effectively identify patients at risk of non-adherence (NA) or medication errors (ME), leading to unsafe practices and increased healthcare costs, hospitalizations, and poor health outcomes.

Innovation Solution

A wearable device equipped with sensors and interactive visual/audio platforms monitors medication adherence and physical/mental wellbeing, providing real-time feedback and alerts, and connects to a MAM center for remote monitoring and intervention.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If periodic review appointments are used for medication monitoring, then patients receive regular medical attention, but clinic time, staff time, and facility time are consumed and cannot identify patients at risk of non-adherence

Engineering Contradiction:
Improvemedication monitoring effectivenessVSAvoidclinic time, staff time, facility time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The wearable device continuously monitors medication adherence and provides real-time feedback to both patients and healthcare providers. Adherence data is automatically transmitted to a remote monitoring system, enabling proactive identification of patients at risk without requiring periodic clinic visits for status checks.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

A remote monitoring system acts as an intermediary between the patient's wearable device and healthcare providers. This intermediary continuously analyzes adherence data, identifies at-risk patients, and alerts providers, eliminating the need for direct patient-provider interaction for routine monitoring.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Ease of operation

If simplified medicines information is provided through MaPPs system, then patient understanding is improved, but non-adherence remains a challenge

Engineering Contradiction:
Improvepatient understanding of medicationVSAvoidmedication adherence
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The system provides continuous real-time feedback on actual medication-taking behavior through the wearable device, going beyond simplified information provision. This objective adherence data helps patients understand their actual behavior patterns and motivates improved adherence through visible progress tracking.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The patent replaces reliance on patient self-reporting and simplified information provision with an automated sensor-based monitoring system. The wearable device objectively measures adherence behavior, eliminating the gap between understanding medication instructions and actual adherence execution.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Reliability

If healthcare staff review medications periodically, then patients receive professional guidance, but patients at risk of non-adherence cannot be identified in between reviews

Engineering Contradiction:
Improveprofessional medication guidanceVSAvoidtime between reviews
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The wearable monitoring system provides continuous adherence monitoring between periodic professional reviews, eliminating gaps in surveillance. The system continuously collects, transmits, and analyzes adherence data, ensuring patients are constantly monitored rather than only at discrete review points.

Inventive Principle:
Principle #20Continuity of useful action

Solution Approach 2:

The remote monitoring system serves as a continuous intermediary that maintains professional oversight between patient-provider encounters. It continuously analyzes adherence data and proactively alerts providers to at-risk patients, ensuring professional guidance is effectively maintained continuously rather than periodically.

Inventive Principle:
Principle #24Intermediary (Mediator)

4Reliability

If medication adherence is monitored through traditional methods, then some patients are reviewed, but early intervention cannot be provided to prevent decline

Engineering Contradiction:
Improveadherence review coverageVSAvoidtime to detect and intervene
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The system performs preliminary detection of adherence problems before they lead to clinical decline. By continuously monitoring and analyzing adherence patterns in real-time, the system identifies at-risk patients early and triggers proactive interventions, preventing deterioration rather than responding to established problems.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

Real-time adherence feedback enables immediate detection of problematic patterns. The system continuously monitors behavior, provides instant feedback when adherence deviations occur, and triggers timely interventions, eliminating the delay inherent in traditional periodic review methods.

Inventive Principle:
Principle #23Feedback

Data Source

PatentUS12502126B2Wearable device
Publication Date: 2025.12.23 PRICE DAWN
  • US12502126B2 patent drawing
  • US12502126B2 patent drawing
  • US12502126B2 patent drawing

AI summary

A wearable medication adherence monitoring (MAM) device for wearing by a patient, including an operating unit (OU) which includes: a wireless communications unit (WCU); a processing unit (CPU); a memory unit; and one or a plurality of peripheral interface(s) with a plurality of input peripherals; and further includes the plurality of input peripherals and output peripherals in a MAM unit (MAMU) which includes: an interactive visual display unit (VDU) including a visual display (VD) and a VD patient interaction (PI) tool (VDTOOL); and an interactive audio platform (AP) including an audio output unit (SPK) and an audio PI tool (MIC; and one or a plurality of sensor unit(s) (SU(s)) including at least one biomarker sensor, and optionally at least one biometric sensor; included in one or a plurality of attachment units (AU) for wearing of the device on or about a body part of the patient.